BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.78B
AUM Growth
+$316M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$30.6M
2
+$21.7M
3
+$20.1M
4
TSRO
TESARO, Inc.
TSRO
+$19.7M
5
NKTR icon
Nektar Therapeutics
NKTR
+$19.5M

Top Sells

1
+$32.4M
2
+$30.4M
3
+$28.3M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$19.6M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$15.5M

Sector Composition

1 Healthcare 96.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$447M 11.83%
8,666,334
2
$388M 10.28%
3,158,090
-159,663
3
$267M 7.07%
2,984,298
-340,000
4
$264M 6.99%
1,370,445
-30,000
5
$263M 6.96%
3,808,322
+50,000
6
$183M 4.84%
1,314,428
-30,000
7
$170M 4.49%
2,197,931
8
$151M 4%
1,071,373
9
$151M 3.99%
1,954,596
-420,000
10
$150M 3.97%
8,247,860
11
$146M 3.85%
3,282,964
+100,000
12
$120M 3.17%
1,370,538
+230,000
13
$117M 3.1%
6,590,276
+389,363
14
$114M 3.03%
2,931,802
+505,000
15
$94.7M 2.51%
3,567,882
+60,000
16
$83.6M 2.21%
2,386,471
-97,600
17
$80.8M 2.14%
200,000
-70,000
18
$69.3M 1.83%
1,385,002
+247,117
19
$69M 1.82%
545,719
20
$64.1M 1.7%
2,990,412
+330,000
21
$55.7M 1.47%
734,739
+285,690
22
$53.4M 1.41%
2,822,641
+290,000
23
$51.5M 1.36%
56,333
+21,333
24
$49.4M 1.31%
2,785,000
+1,725,000
25
$47.7M 1.26%
2,200,000
1
2